Skip to main content
GRAL
NASDAQ Life Sciences

Galleri Trial Shows 26% Reduction in Stage IV Cancer Diagnoses, Misses Primary Endpoint

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$73
Mkt Cap
$3.076B
52W Low
$29.95
52W High
$118.84
52W Position info
144% above low
Off High info
39% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

GRAL has more than doubled off its 52-week low of $29.95.

Summary

GRAIL announced full results from its NHS-Galleri trial, showing its blood test reduced Stage IV cancer diagnoses by 22% in the second round and 26% in the third. This is a significant finding for late-stage detection. However, the trial did not meet its combined primary endpoint for Stage III/IV cancers in aggregate, presenting a mixed efficacy profile. This outcome will require careful evaluation of the test's market potential and regulatory path.

At the time of this announcement, GRAL was trading at $73.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $29.95 to $118.84. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GRAL - Latest Insights

GRAL
Nov 05, 2026, 4:09 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $119.13
Real-time Price: $103.40 info
Change: -$15.73 (-13%) info
Market Cap: $4.714B info
GRAL
Nov 04, 2026, 4:02 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $135.67
Real-time Price: $103.40 info
Change: -$32.27 (-24%) info
Market Cap: $4.714B info
GRAL
Sep 23, 2026, 6:17 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $108.52
Real-time Price: $103.40 info
Change: -$5.12 (-5%) info
Market Cap: $4.714B info
GRAL
Sep 23, 2026, 8:07 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $109.91
Real-time Price: $103.40 info
Change: -$6.51 (-6%) info
Market Cap: $4.714B info
GRAL
Sep 21, 2026, 4:34 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $107.97
Real-time Price: $103.40 info
Change: -$4.57 (-4%) info
Market Cap: $4.714B info